Cancer Clinical Trial
Official title:
Remote Electronic Patient Monitoring in Oncology Patients
The goal of this research is to study an intervention, which the investigators call "Remote
Electronic Patient Monitoring," that entails vital sign data (enabled with smart algorithms
for notification) and patient-reported outcomes (PROs), (such as physical and psychological
symptoms) intended to address and manage any concerning issues and or diagnoses identified.
Specifically, the plan is a study of oncology patients who will use the Gaido system for up
to 21 days or per physician order.
Gaido Health's Remote Patient Monitoring Solution v1.0 is a wireless remote monitoring system
intended for use by healthcare professionals for the collection of physiological data in home
and healthcare settings. Patient information is displayed on a computer located at the
medical institution. Every 15 minutes, a measurement is plotted on the User Interface of
heart rate / respiration rate (by a Biovotion device). A non-invasive blood pressure (by an
Omron device) along with an oral digital thermometer reading are taken per clinician orders
and displayed on the Gaido dashboard. Wearable data are transmitted wirelessly from the
Biovotion sensor (heart rate and respiratory rate) to the patient's smart phone that relays
data to a cloud-based server for storage and analysis. Oral temperature and blood pressure
are entered by the patient or care-giver into the patient's smart phone that relays data to a
cloud-based server for storage.
The Remote Patient Monitoring system uses algorithms that indicate when patient vitals and
patient reported outcomes have changed. Automatic patient surveys are sent to the patient
with results displayed both on the computer located in the medical institution and the
patient's smart phone. The patient surveys gather patient reported symptoms which are
intended to be used in combination with vital signs to support decision-making. The system is
intended for use with patients 18 years of age and older who are cared for by healthcare
professionals.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|
||
| Recruiting |
NCT05318196 -
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
|
||
| Recruiting |
NCT04444544 -
Quality of Life and High-Risk Abdominal Cancer Surgery
|